WASHINGTON — The American Council of Cannabis Medicine (ACCM) launched the Legislative Medical Cannabis Toolkit, a resource designed to help federal, state, and local policymakers understand the evolving medical cannabis landscape and develop responsible, patient-centered public policy.
Developed for legislators, congressional staff, government agencies, and regulatory officials, the toolkit addresses patient access, physician participation, whole-plant and whole-flower protections, insurance integration, industry standards, technology connectivity, scientific research, small-business protections, and the continued role of state medical cannabis programs.
It also examines critical issues facing policymakers as medical cannabis becomes more integrated with mainstream healthcare, including continuity of care, physician education, insurance reimbursement, patient privacy, research access, and the potential effects of changes to federal cannabis scheduling.
“Medical cannabis policy is entering one of the most important periods in its history, and legislators need reliable information from people who understand patient care and the operational realities of the industry,” said ACCM Executive Committee Chair Doug Benns. “This toolkit provides a practical starting point and direct access to physicians, patients, researchers, insurance professionals, agricultural experts, dispensary operators, and regulatory specialists.”
In conjunction with the toolkit, ACCM is making its Legislative Response Team available to legislative offices and government agencies. The team can provide policy briefings, proposed-bill reviews, committee preparation, background materials, stakeholder roundtables, technical assistance, and qualified experts who can provide testimony or answer policy questions.
“Responsible policy must begin with patients and preserve access to the medicines and delivery methods upon which they currently depend,” said Dan Rush, ACCM legislative subcommittee member and chair of the Patient First Coalition Medical Cannabis Committee. “Policymakers need access to a broad range of informed voices before making decisions that could affect millions of patients, caregivers and families.”
ACCM can assemble specialized response teams based on the needs of an individual office, committee, or agency. Participants may include healthcare professionals, patient advocates, researchers, insurance experts, compliance specialists, technology providers, legal and regulatory professionals, dispensary operators, and representatives of medical cannabis businesses of every size.
A central focus of the initiative is ensuring future reforms advance research and innovation without eliminating whole-plant or whole-flower options, disrupting state medical programs, or creating compliance structures that exclude smaller organizations. ACCM also supports policies that allow qualified healthcare professionals to discuss medical cannabis openly and responsibly with patients.
“As medical cannabis becomes more integrated with mainstream medicine, consistent standards will be essential to protecting patients and building public confidence,” said Priscilla Agoncillo, ACCM Standards Committee Chair. “Standards should promote safety, privacy, education, transparency, and accountability while supporting innovation and patient-focused solutions.”
Legislative offices may contact ACCM to request the toolkit, schedule a briefing, obtain expert testimony, organize a stakeholder discussion, or receive assistance reviewing legislation and regulatory proposals.
About ACCM
Founded in 2016 as a Capitol Hill working group, ACCM is a national organization representing medical cannabis retailers, producers, healthcare professionals, researchers, insurers, patient advocates, and wellness providers. ACCM works to expand safe, effective, and equitable access through policy advancement, physician engagement, and patient advocacy.
